Mattern Capital Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$338K Hold
2,211
0.04% 149
2025
Q4
$305K Hold
2,211
0.04% 153
2025
Q3
$284K Sell
2,211
-5
-0.2% -$610 0.03% 156
2025
Q2
$268K Buy
2,216
+5
+0.2% +$564 0.03% 158
2025
Q1
$246K Hold
2,211
0.03% 158
2024
Q4
$215K Hold
2,211
0.03% 157
2024
Q3
$254K Hold
2,211
0.03% 148
2024
Q2
$235K Hold
2,211
0.03% 153
2024
Q1
$214K Hold
2,211
0.03% 157
2023
Q4
$223K Sell
2,211
-39
-2% -$3.76K 0.03% 132
2023
Q3
$229K Sell
2,250
-36
-2% -$3.65K 0.04% 130
2023
Q2
$231K Buy
+2,286
New +$229K 0.04% 127
2020
Q2
Sell
-2,631
Closed -$217K 107
2020
Q1
$217K Sell
2,631
-92
-3% -$8.21K 0.07% 100
2019
Q4
$258K Buy
+2,723
New +$244K 0.07% 95

Other funds holding NVS

Mattern Capital Management's NVS Position: Q1 2026 in Review

Mattern Capital Management held its Novartis (NVS) position steady in Q1 2026 at 2,211 shares worth $338K. The position accounts for 0.04% of the portfolio, ranked #149.

Mattern Capital Management first reported a position in NVS in Q4 2019 and has held it in 14 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Mattern Capital Management held 2,211 shares of Novartis worth $338K as of Q1 2026.
  • Mattern Capital Management left its Novartis share count unchanged in Q1 2026.
  • Novartis made up 0.04% of Mattern Capital Management's portfolio in Q1 2026, its #149 holding.
  • Mattern Capital Management first reported a position in Novartis in Q4 2019 and has held it in 14 quarters since.
  • 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Mattern Capital Management's 13F filing for Q1 2026, filed 4 May 2026.